Neil Maresky
Plus aucun poste en cours
Fortune : 34 119 $ au 31/03/2024
Profil
Neil Maresky is currently the Chief Executive Officer & Director at Psyence Biomed Corp.
and Psyence Biomedical Ltd.
He previously served as the Chief Executive Officer & Director at Psyence Group, Inc. from 2021 to 2024.
Neil also held positions at Novartis International AG as the Director-Drug Safety & Pharmacoepidemiology.
Prior to that, he was the Vice President-Scientific Affairs at AstraZeneca Canada, Inc. from 2010 to 2021 and at Wyeth Canada ULC.
Neil obtained his doctorate degree from the University of the Witwatersrand in 1987.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PSYENCE GROUP INC.
0,91% | 14/11/2023 | 1 218 523 ( 0,91% ) | 34 119 $ | 31/03/2024 |
Postes actifs de Neil Maresky
| Sociétés | Poste | Début |
|---|---|---|
Psyence Biomed Corp.
 Psyence Biomed Corp. BiotechnologyHealth Technology Psyence Biomed Corp. is a life science biotechnology company, which engages in the provision of natural psychedelics solutions for the treatment of psychological trauma and mental health disorders. The company was founded on May 21, 2020 and is headquartered in Toronto, Canada. | Chief Executive Officer | - |
Anciens postes connus de Neil Maresky
| Sociétés | Poste | Fin |
|---|---|---|
| PSYENCE GROUP INC. | Chief Executive Officer | 11/03/2024 |
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 01/06/2021 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Wyeth Canada ULC
 Wyeth Canada ULC Pharmaceuticals: MajorHealth Technology Wyeth Canada ULC manufactures and distributes pharmaceutical products. The company markets products in the areas of women's health care, neuroscience, musculoskeletal therapy, transplantation and immunology, hemophilia, and vaccines. It was founded in 1907 and is headquartered in Markham, Canada. | President | - |
Formation de Neil Maresky
| University of the Witwatersrand | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PSYENCE GROUP INC. | Industrial Services |
| Entreprise privées | 4 |
|---|---|
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Health Technology |
Wyeth Canada ULC
Wyeth Canada ULC Pharmaceuticals: MajorHealth Technology Wyeth Canada ULC manufactures and distributes pharmaceutical products. The company markets products in the areas of women's health care, neuroscience, musculoskeletal therapy, transplantation and immunology, hemophilia, and vaccines. It was founded in 1907 and is headquartered in Markham, Canada. | Health Technology |
Psyence Biomed Corp.
Psyence Biomed Corp. BiotechnologyHealth Technology Psyence Biomed Corp. is a life science biotechnology company, which engages in the provision of natural psychedelics solutions for the treatment of psychological trauma and mental health disorders. The company was founded on May 21, 2020 and is headquartered in Toronto, Canada. | Health Technology |
